Country | Patients (N) | documented FGM/C cases | FGM/C country prevalence (23,25) | Expected FGM/C cases |
---|---|---|---|---|
Nigeria | 211 | 6 (2,2%) | 19% | 40 |
Egypt | 120 | 0 (0%) | 87% | 104 |
Iraq | 89 | 0 (0%) | 7% | 6 |
Ghana | 27 | 0 (0%) | 4% | 1 |
Somalia | 19 | 8 (42,1%) | 98% | 19 |
Sierra Leone | 14 | 0 (0%) | 86% | 12 |
Indonesia | 13 | 0 (0%) | 49% | 6 |
Kenya | 13 | 1 | 21% | 3 |
Ethiopia | 8 | 0 (0%) | 65% | 5 |
Cameroon | 4 | 0 (0%) | 1% | 0 |
Eritrea | 3 | 0 (0%) | 83% | 3 |
Sudan | 3 | 1 | 87% | 3 |
Uganda | 3 | 0 (0%) | 0% | 0 |
Central African Republic | 2 | 0 (0%) | 24% | 1 |
Gambia | 2 | 1 | 76% | 2 |
Ivory Coast | 2 | 0 (0%) | 37% | 1 |
Burkina Faso | 1 | 0 (0%) | 76% | 1 |
Chad | 1 | 0 (0%) | 38% | 0 |
Mali | 1 | 0 (0%) | 89% | 1 |
Niger | 1 | 0 (0%) | 2% | 0 |
Senegal | 1 | 0 (0%) | 24% | 0 |
Yemen | 1 | 0 (0%) | 19% | 0 |
Total | 539 | 17 | 208 |